Abstract:There is currently no disease-modifying therapy for Huntington’s disease (HD) and two recent clinical trials testing antisense oligonucleotides failed. We recently described a small molecule, MK-28, which restored homeostasis in HD models by specifically activating PKR‐like ER kinase (PERK) and thus boosting neuroprotection by the unfolded protein response (UPR), and reducing endoplasmic reticulum (ER) stress, a central cytotoxic mechanism in HD and other neurodegenerative diseases. Here we have tested the lon… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.